CXMT puts shy of $2.7B of excess IPO proceeds into DRAM R&D, testing
The company had 36.8 billion yuan in excess proceeds, making the latest 18 billion yuan allocation almost half of that pool.
The company had 36.8 billion yuan in excess proceeds, making the latest 18 billion yuan allocation almost half of that pool.

CXMT founder and memory titan GigaDevice’s venture arm reportedly behind the AI champion with a 5 billion yuan bet.
CXMT said the G5 yield ramp-up will take time and that new products must go through customer testing and certification before broader adoption.

The company expects the technology eventually to expand beyond flagship smartphones into smart vehicles, edge servers and wearables.
MSCI announced on July 28 that CXMT had met the eligibility criteria, with the inclusion taking effect on August 10.
If prototype testing meets expectations, its domestically developed LPDDR6 chips could enter large-scale production within the year.

But today, CXMT is refusing to make even a price concession. The reason is not arrogance. The rules of the game have changed.

Rather than seeking a quick exit, the consortium positioned itself as a long-term partner in a strategic technology race.

The closing price was only 1% below the opening level, with the stock trading at elevated levels throughout the session.

CXMT’s listing marks the largest semiconductor IPO in A-share history and one of Asia’s biggest public offerings this year.